NYHF 19th Forum:
President Joe Biden's Executive Order on Biotech:
The Impact on Korean Biopharma Industry
November 10, 2022 (Thursday)
4:00 PM – 5:00 PM ET
4:00-5:00 PM Session
"President Joe Biden's Executive Order on Biotech: The Impact on Korean Biopharma Industry"
The New York Health Forum will convene a special webinar to contextualize President Joe Biden's Executive Order (EO 14081) announced in September 2022 and examine how the US government's approach to launching a National Biotechnology and Biomanufacturing Initiative will impact the Korean biopharma industry with featured speakers Dr. Joe McMenamin, MD, JD and Dr. Chul S. Hyun, MD, PhD
Joseph McMenamin, MD, JD | CLO and EVP, W Medical Strategy Group
Chul S. Hyun, MD, PhD, MPH | Board Member, W Medical Strategy Group
John Oh (Moderator) | Project Associate, W Medical Strategy Group
Joseph McMenamin, MD, JD
CLO and EVP, W Medical Strategy Group
Joseph P. McMenamin, M.D., J.D. practices law at McMenamin Law Offices, PLLC., in Richmond, Virginia. He is also CLO and EVP for WMSG. Joe has some 37 years’ experience in defending healthcare organizations and providers against a variety of allegations in state and federal court. He also has advised them on law applicable to Internet and marketing communications, digital health issues, augmented intelligence, the conduct of human research, informed consent, risk management, and regulatory and contract matters. Previously, he practiced emergency medicine for seven years at hospitals in Pennsylvania and Georgia.
Chul S. Hyun, MD, PhD, MPH
Board Member, W Medical Strategy Group
Chul S. Hyun, MD, PhD, MPH, has practiced gastroenterology and hepatology in New York and New Jersey since 1992. With his experience in clinical medicine, community health, and the US and global physician networking, he is interested in facilitating healthcare ecosystems to optimize their business operations, improve clinical outcomes, and create a more community and patient-centric healthcare experience.
John Oh (Moderator)
Project Associate, W Medical Strategy Group
John Oh is a Project Associate with W Medical Strategy Group. Since joining, he has been working
on projects dealing with US biopharma PR and marketing, strategic partnership development,
as well as cross-border transactions. His work experience also includes marketing planning and
related strategy development. John graduated from Rutgers University with a Biology Major.